Skip to main content
. 2019 Dec 20;16(1):66–70. doi: 10.4103/jmas.JMAS_158_18

Table 2.

Perioperative data

RAS-group OS-group P
Mean operative time, min (range) 245.6±92.4 (110–495) 267.8±69.0 (135–415) 0.32
Spleen preserving, n (%) 17 (63) 9 (33.3) <0.05
Conversion to laparoscopic/open approach, n (%) 0
Intraoperative complications, n (%) 0 0 1
Estimate blood loss, ml (range) 179 (100–250) 204 (100–300) 0.05
Median hospital stay, days (range) 8 (3–25) 12 (7–26) <0.01
2016 ISGPS POPF, n (%) 3 (11.1) 3 (11.1) 1
 Biochemical leak 7 (25.9) 8 (29.6) 0.76
 Grade B POPF 3 (11.1) 3 (11.1) 1
 Grade C POPF 0 0 1
Intra-abdominal collection, n (%) 8 (29.6) 5 (18.5) 0.34
Medical complications, n (%) 2 (7.4) 3 (11.1) 0.64
 Clavien-Dindo Grade I 0 1 (3.7) 0.31
 Clavien-Dindo Grade II 2 (7.4) 2 (7.4) 1
Post-operative mellitus diabetes, n (%) 5 (18.5) 5 (18.5) 1
Reoperation, n (%) 0 1 (3.7) 0.31
Mortality, n (%) 0 0 1

POPF: Post-operative pancreatic fistula, ISGPS: International Study Group on Pancreatic Surgery, OS: Open surgery, RAS: Robotic-assisted surgery